Patient cost responsibility up for guideline-discordant care
(HealthDay)—For patients with metastatic breast cancer (MBC), receipt of National Comprehensive Cancer Network Guideline-discordant care is associated with higher patient cost responsibility, according to a study published ...
Oct 18, 2019
0
1